Inasaridze, K. (2021). Behavioral activation method for depression therapy [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/ge8s3

Summers, C. (2021, June 8). Oxygen shortages are killing thousands. Why aren’t we doing more about this? | Charlotte Summers. The Guardian. http://www.theguardian.com/commentisfree/2021/jun/08/oxygen-shortages-killing-vaccines-drugs

Bahrampour, T. (n.d.). For those who lost loved ones to covid, there is no return to normal. Washington Post. Retrieved June 9, 2021, from https://www.washingtonpost.com/local/social-issues/covid-widows-reopening/2021/06/07/7a55f9e6-c3bc-11eb-8c18-fd53a628b992_story.html

Clinical Key

The RECOVERY trial in Oxford, with 5795 patients who were randomly allocated to receive convalescent plasma treatment and 5763 who received usual care alone, found that there was no statistically significant difference for 28-day mortality (24% for both groups, p-0.93) or the proportion of patients discharged from hospital within 28 days (66% CP vs 67% control, p=0.50) for the two groups. Additonally for patients without mechanical ventilation, there was no stastically significant difference in the intubation rate (28% CP vs 29% control, p=0.79).

https://doi.org/10.1101/2021.03.09.21252736

The trial showed convalescent plasma therapy had no benefit to patients with COVID-19. As a result the UK's health service has stopped collecting convalescent plasma from patients who had recovered from COVID-19.

https://www.bbc.co.uk/news/health-55681051

Additonally the NIH have halted a convalescent plasma trial for COVID-19 patients with mild symptoms stating that the "study shows that the treatment is safe, but provides no signifcant benefit in this group".

https://www.nih.gov/news-events/news-releases/nih-halts-trial-covid-19-convalescent-plasma-emergency-department-patients-mild-symptoms

"private facebook page" is the dumbest thing on this page..

https://www.npr.org/sections/health-shots/2020/01/11/795010044/feeling-artsy-heres-how-making-art-helps-your-brain

https://oefy.com/blogs/art-therapy/art-therapy-to-process-emotions

Bizarre...

Anonymous. (2021, January 20). This is what it’s like to be an intensive care unit nurse right now. The Guardian. http://www.theguardian.com/commentisfree/2021/jan/20/intensive-care-nurse-eu-europeans-health-britain

I think this is an awesome mission statement and that this owner/website designer took a business class and they understand mission, values, and vision.

some literature on organizations such as [[MyPsySpace]] and [[Virtual Reality Medical Center]]

[[micro-tonal therapy]] that uses empathy as resonance

This solution based therapy focuses on trying to get people active and engaged with life even when depressed.

It is important to help patients experience those little positive events. These events can help people get back on track.

This is all about solution based therapy. We need concrete ways of fixing our problems.

Vagueness is a cognitive avoidance strategy. It is a way to avoid digging deep.

It is safer for our feelings to stay vague, but that is not where we need to improve.

Just as one would expect, it appears that antioxidants can protect against this type of damage. Note that the study was in rats, but we have every reason to think it would work in humans. In particular, several studies showing that dietary antioxidants protect skin from sunlight in humans; it's should be essentially the same thing for the eyes.

This is not in the least surprising. Dietary antioxidants also protect the skin during sunlight exposure.

Oxidative stress likely also plays a role in diabetic retinopathy. It plays a role in the aging process itself. That said, there is probably a limit to protective powers of antioxidants. Nonetheless, I don't think that that limit has ever been realized in any population. I doubt we've even come close in rats.

Ponchner, D. (n.d.). Costa Rica Readies Horse Antibodies for Trials as an Inexpensive COVID-19 Therapy. Scientific American. Retrieved September 8, 2020, from https://www.scientificamerican.com/article/costa-rica-readies-horse-antibodies-for-trials-as-an-inexpensive-covid-19-therapy/

What is the success rate of these programs? They DO NOT work... People with addiction problems need one on one help so they can understand their situation and what's going on i in their heads, and how they are impacting their children....

The groups give them a swamp/ place to dwell. With Lillian, it was a place for her to feel sorry for herself and for others to "comfort" her. When she came home, we were the bad guys for not understanding.

• programs are not a one size fit all. If they work at all.

[[TalkSpace]] has had some questionable pratices around ethics recently - source

Services like [[InkBlot]], your works [[Health Care Spending Account]] - in the past I had good luck with the Aspiria - they got me setup with a good therapist from Shift Collab Therapy

Even trying to figure out what my starting point was too much - but being able to use a service like that to help connect me was really important.

Gorey, C. (2020, June 29). RCSI team to start trial for promising Covid-19 therapy for severe infections. Silicon Republic. https://www.siliconrepublic.com/innovation/rcsi-trial-covid-19-therapy-alpha-1-antitrypsin

Ferreira, L. M. R., & Mostajo-Radji, M. A. (2020). Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/cyqx8

Qin, M., Cao, Z., Wen, J., Yu, Q., Liu, C., Wang, F., Yang, F., Li, Y., Fishbein, G., Yan, S., Xu, B., Hou, Y., Ning, Z., Nie, K., Jiang, N., Liu, Z., Wu, J., Yu, Y., Li, H., … Lu, Y. (2020). An Antioxidant Enzyme Therapeutic for COVID-19. BioRxiv, 2020.07.15.205211. https://doi.org/10.1101/2020.07.15.205211

Science Facebook Live: Understanding SARS-CoV-2 structure informs vaccine design, clinical trials. (2020, March 20). https://www.youtube.com/watch?v=nOzEx3OpKe8

Luban, J., Sattler, R., Mühlberger, E., Graci, J. D., Cao, L., Weetall, M., Trotta, C., Colacino, J. M., Bavari, S., Strambio-De-Castillia, C., Suder, E. L., Wang, Y., Soloveva, V., Cintron-Lue, K., Naryshkin, N. A., Pykett, M., Welch, E. M., O’Keefe, K., Kong, R., … Peltz, S. (2020). The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines. BioRxiv, 2020.08.05.238394. https://doi.org/10.1101/2020.08.05.238394

Chaudhuri, S., Lo, A. W., Xiao, D., & Xu, Q. (2020). Bayesian Adaptive Clinical Trials for Anti‐Infective Therapeutics during Epidemic Outbreaks (Working Paper No. 27175; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27175

Kominers, S. D., Pathak, P. A., Sönmez, T., & Ünver, M. U. (2020). Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design (Working Paper No. 27143; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27143

Free webinar gives top tips on effective video therapy | BPS. (2020, April 24). British Psychological Society. https://www.bps.org.uk/news-and-policy/free-webinar-gives-top-tips-effective-video-therapy

Nohelty, K., Hirschfeld, L., & Miyake, C. (2020, June 17). A Measure for Supporting Implementation of Direct Telehealth Therapy with Treatment Integrity. https://doi.org/10.31234/osf.io/pe5z8

Wade, S. L., Gies, L. M., Fisher, A. P., Moscato, E. L., Adlam, A. R., Bardoni, A., Corti, C., Limond, J., Modi, A. C., & Williams, T. (2020). Telepsychotherapy with children and families: Lessons gleaned from two decades of translational research. Journal of Psychotherapy Integration, 30(2), 332–347. https://doi.org/10.1037/int0000215

Freeston, M. H., Tiplady, A., Mawn, L., Bottesi, G., & Thwaites, S. (2020, April 14). Towards a model of uncertainty distress in the context of Coronavirus (Covid-19). https://doi.org/10.31234/osf.io/v8q6m

Blanchard, M. A., & Heeren, A. (2020). Why We Should Move from Reductionism and Embrace a Network Approach to Parental Burnout? [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/y34cq

Arslan, G., Yıldırım, M., Tanhan, A., Buluş, M., & Allen, K.-A. (2020). Coronavirus Stress, Optimism-Pessimism, Psychological Inflexibility, and Psychological Health: Testing the Psychometrics of the Coronavirus Stress Measure [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/n6dcj

Lipsitch, M., Perlman, S., & Waldor, M. K. (2020). Testing COVID-19 therapies to prevent progression of mild disease. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30372-8

Psychiatry, T. L. (2020). Mental health and COVID-19: Change the conversation. The Lancet Psychiatry, 0(0). https://doi.org/10.1016/S2215-0366(20)30194-2

Sung, J., Dobias, M., & Schleider, J. L. (2020, April 29). Single-Session Interventions: Complementing and Extending Evidence-Based Practice. https://doi.org/10.31234/osf.io/z7bw2

Fischer, R., Karl, J. A., Bortolini, T., Zilberberg, M., Robinson, K., Rabelo, A. L. A., … Mattos, P. (2020, April 22). Rapid review and meta-meta-analysis of self-guided interventions to address anxiety, depression and stress during COVID-19 social distancing. https://doi.org/10.31234/osf.io/ndyf4

DA SILVA, C. M. N. G. (2020, April 13). Who takes care of health professional?. https://doi.org/10.31234/osf.io/n4j98

Mullard, A. (2020). Flooded by the torrent: The COVID-19 drug pipeline. The Lancet, 395(10232), 1245–1246. https://doi.org/10.1016/S0140-6736(20)30894-1

Fronapfel, B. H., & Demchak, M. (2020, April 12). School’s Out for COVID-19: 50 Ways BCBA Trainees in Special Education Settings Can Accrue Independent Fieldwork Experience Hours During the Pandemic. https://doi.org/10.31234/osf.io/cr3uv

British Psychological Society. Responding to Coronavirus: Resources and support. https://www.bps.org.uk/responding-coronavirus

COVID-19. (n.d.). Retrieved April 17, 2020, from https://www.wwtf.at/covid/index.php?lang=EN

Abdulla, A., Wang, B., Qian, F., Kee, T., Blasiak, A., Ong, Y. H., Hooi, L., Parekh, F., Soriano, R., Olinger, G. G., Keppo, J., Hardesty, C. L., Chow, E. K., Ho, D., & Ding, X. (n.d.). Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention. Advanced Therapeutics, n/a(n/a), 2000034. https://doi.org/10.1002/adtp.202000034

COVID-19 therapy, vaccine, epidemiology and policy development research boosted by twenty-one new projects—UK Research and Innovation. (n.d.). Retrieved April 21, 2020, from https://www.ukri.org/news/covid-19-research-boosted-by-new-projects/

Clinical trials will most certainly first include those patients with the highest risk of relapse. However, long term, everything will depend on the risk/ benefit trade off: if an effective, simple, well-tolerated and cost-effective treatment was available (let's imagine a single short low-dose PD1 for any early Melanoma patient) that prevented progression for most patients would be very different from a highly toxic, expensive treatment that doesn't work for everyone (think Ipi 10mg/kg adjuvant)- so everything is in the trade-off

I quibble with the use of the word "extreme" here. The examples in this article seem more like issues of strong beliefs or unthinking comments, but hot moments also include deeply personal disclosures. Reserving counseling for "extreme" cases is stigmatizing, especially as we see more students in higher ed who have experience of mental health treatment. Many students involved in "hot moments" might benefit from being referred to the resources available in student life offices and/or counseling and faculty should be aware enough of these resources to suggest them with comfort.

writing = therapy :)

therapy with horses

Isn't the flipped experiment a clear indication that FTT (fecal transplant therapy) can help alleviating IBS? If the reverse is true, there might be great value in getting your microbiome fixed/infused by healthy microbiota from donors.